Atomistic description of protein fibril formation has remained prohibitive due to the complexity and long timescales of the conformational search problem. Here, we develop a multi-scale approach that combines a large number of atomistic molecular dynamics simulations in explicit solvent to derive Markov State Models (MSMs) for simulation of fibril growth. The search for the in-registered fully bound fibril state is modeled as a random walk on a rugged 2D energy landscape along enumerated β-sheet registry and hydrogen bonding states, whereas interconversions among nonspecific bound states and between nonspecific and hydrogen-bounded states are derived from kinetic clustering analysis. The reversible association/dissociation of an incoming peptide and overall growth kinetics are then computed from MSM trajectories. This approach is applied to derive a comprehensive description of fibril elongation of wild-type Aβ16-22 and how it is modulated by phenylalanine to cyclohexane (CHA) mutations. The resulting models recapitulate the experimental observation that mutants CHA19 and CHA1920 accelerate fibril elongation, but have a relatively minor effect on the critical concentration for fibril growth. Importantly, the kinetic consequences of mutations arise from a complex perturbation of the network of productive and non-productive pathways of fibril grown. This is consistent with the expectation that nonfunctional states will not have evolved efficient folding pathways and, therefore, will require a random search of configuration space. This study highlights the importance of describing the complete energy landscape when studying the elongation mechanism and kinetics of protein fibrils.
Introduction
Aggregation of mis-folded proteins has been implicated in many devastating and currently incurable medical disorders such as like Alzheimer's and prion diseases. (1) (2) (3) Originally, insoluble amyloid fibrils were considered to be the main neurotoxic agents. However, recent evidence suggests that soluble metastable amyloid β (Aβ) oligomers are more likely responsible for neuronal injury occurring in Alzheimer's disease (AD). (4) (5) (6) (7) (8) This observation implies that inhibition of oligomer formation or even promotion of fibril formation could be a promising therapeutic strategy. (9, 10) However, owing to the complexity of the aggregation process and metastability of the intermediate states, identifying the most promising target species for therapeutic intervention is still challenging.(11) Therefore, it is important to deduce molecular mechanisms that control the kinetics of state transitions which, in turn, determine the populations of different Aβ aggregate species.
Elucidating the molecular mechanisms of amyloid aggregation requires detailed knowledge of the kinetics and thermodynamics of substate transitions during aggregation. Previous experiments suggest Aβ fibrils are likely grown one monomer a time, which can be described by a two-step (Dock and Lock) model. (12) (13) (14) (15) In this model, an Aβ monomer rapidly adheres to a preformed fibril (dock step), followed by a slow lock step where the unstructured incoming peptide rearranges into an extended fibrillar conformation. (8, 12, 16) However, further mechanistic dissection of the aggregation process using experimental techniques is hindered by the presence of numerous metastable substates that interconvert rapidly.(3) Molecular dynamics (MD) simulation is a powerful tool which can provide a detailed molecular picture of the dynamics to complement experimental studies (17) (18) (19) . However, the experimentally estimated elongation rate is roughly about a second per layer, (20, 21) which is beyond the currently feasible timescale with allatom/united-atom simulations. Although this timescale is available by simplified coarse-grained (CG) approach, (19, (22) (23) (24) (25) (26) reduced resolution of these models makes it challenging to properly distinguish protein sidechains with similar properties and capture mutational effects on the amyloid aggregation.
The slow elongation rate of amyloid fibrils is due to a relatively flat energy landscape which is pitted with numerous local minima. (27) Since the long aggregation time arises from transitions between substates, the problem of simulating the elongation process can be solved by efficiently sampling the transitions between different substates with proper reaction coordinates. Multi-scale methods and enhanced sampling have been applied to the simulation of amyloid aggregation. (28) (29) (30) (31) However, reproducing the kinetic network requires not only the productive pathways, but also non-productive pathways, to be adequately sampled, which is challenging for currently available enhanced-sampling techniques.
We have recently developed a theoretical and computational framework that can systematically explore productive and unproductive pathways of protein fibril growth. (27, 32) In this framework, the hydrogen bonding (H-bond) number and alignment (referred to as the 'registry' here) between an incoming peptide and the existing fibril core are used as the primary reaction coordinates of the aggregation process. The slow process of exploring different registries is then converted to a series of H-bond formation and breakage events. Since the H-bond formation and breakage occur on the nanosecond timescale, carefully designed simulations can be deployed to calculate the kinetic parameters of these events and measure how these parameters are affected by variations in protein sequence and/or environmental factors. These microscopic kinetic parameters can be then used to construct Markov State Models (MSMs) for simulating the overall binding and fibril growth process, This is similar to the application of MSMs for protein folding with the important difference that our state space is informed by theory (31, (33) (34) (35) (36) (37) (38) .
We have previously deployed this multi-scale computational algorithm to predict the binding and aggregation process of small amyloid-forming peptides in implicit solvent (27) . That work established the feasibility of using the analytic theory as a framework to access long timescales and more extensive sampling of trajectories. It also successfully recapitulated the effects of single and double mutants on the aggregation kinetics of an amyloid β fragment (Aβ16-22) (1, 39) .
Specifically, the simulation reproduces the non-additive effects of introducing more hydrophobic sidechains, via Phe to cyclohexylalanine (CHA) mutation, on aggregation kinetics. (40) The order of growth rates of WT and two single mutations (WT << CHA19 < CHA20) is correctly predicted by our MSM models derived from implicit solvent simulations. The simulation also correctly predicts that the double mutation (CHA19CHA20) will reduce the fibril growth rate relative to CHA20. However, an inspection of the microscopic pathways led to an unsatisfying conclusion that the non-additive effects arose from the accumulation of small perturbations across the conformational landscape. Furthermore, the MSM had quantitative discrepancies with experiment, highlighted by an over-estimation of the deleterious effect of the double mutant.
In the present work we improve upon our earlier effort by adapting our method for use in explicit solvent. This required an expansion of the state space in the MSM to include the backbone conformational states. We also include a more careful treatment of the weakly bound states that were not considered in the analytic theory. These states (henceforth referred to as non-registered states) lack backbone H-bonds with the fibril and serve as a hub connecting the H-bonding states, which motivates our efforts to sample and include them in an expanded MSM. The improvements result in a satisfying improvement in the quantitative agreement with experiment. Perhaps more importantly, the complex effects of the mutation can be understood based on the funnel model of protein folding (41) (42) (43) , which implies that non-functional states will not evolve efficient folding pathways that are dominated by a small number of trajectories. This situation requires the development of efficient algorithms, such as the one presented here, to properly sample the many small perturbations throughout conformational space that contribute to mutation outcomes.
Results and Discussions

MSM modeling of protein fibril growth
Our model ( Fig. 1 ) is based on the discretization of the elongation process into a series of states based on the microscopic theory of fibril elongation. (27, 32) The elongation process starts from an unstructured monomer in the bulk solvent, which "docks" to a pre-formed fibril core and "locks" as a new structured layer. (12, 13, 16) Thus, the process can be divided into three stages.
The first stage is a diffusion-controlled process, in which the incoming peptide migrates from solvent to a separation distance b. (44, 45) Our treatment of this stage is similar to the Brownian dynamics treatment of diffusion controlled reactions (44, 45) , in which simulations starting from a monomer at the b surface were performed, and the rate of monomers reaching the fibril surface or the monomers reaching an escape distance q were analyzed. If the monomer reaches the q surface, the monomer is considered to have returned to the bulk solvent. The second stage describes the nonspecific interaction between the monomer and fibril without either in-register or off-register backbone H-bonds (non-registered states, blue box in Fig.1 ). This stage ends when the incoming peptide either forms backbone H-bonds with the core peptide, thereby entering the registered stage (third stage), or dissociates from the fibril surface, returning to the unbound state (the q surface).
The third stage represents the peptide's exploration of β-strand alignments by forming or breaking H-bonds (green box in Fig. 1 ). The attempt ends when the molecule either forms a full set of Hbonds in the correct registry (red arrow in Fig. 1 
in which τdiff is the average time for a monomer to diffuse from bulk solvent to the b surface, τresidence is the average time required for a molecule entering the b surface to evolve to either the The peptide is considered return to the bulk solvent if it reaches the q surface. Pcommittor is the probability of the peptide arriving at the fully-bound in-register state (the red path).
fully bound state or return to a separation distance q. τoff represents the average time required for a fully bound peptide to reach the dissociated state (q surface). Pcommittor is the probability that an incoming peptide starting from the b surface becomes incorporated into the fibril in a fully-bound in-register state.
In our previous work (27), we focused on the fibril growth of the central hydrophobic core of Aβ (Aβ16-22 , K16LVFFAE22), (46) which is among the shortest sequences that form amyloid fibrils similar to those by full-length Aβ. (46) (47) (48) All possible H-bond registry states were enumerated and MD simulations in a simple solvent accessible surface area (SASA)-based implicit solvent model (49) were performed to derive the average transition times between neighboring states. The fibril growth of the wild-type and mutant peptides (single mutation CHA19/CHA20 and double mutation CHA19CHA20) were predicted by the MSMs. However, due to the smoother energy surface of the SASA implicit solvent model and lack of solvent friction, conformational fluctuations among non-registered states of the peptide were found to be much faster than sampling of registered states, allowing a single non-registered state to be used in the MSM. Furthermore, simple implicit solvent models like SASA are not capable of accurately describing the peptide conformational equilibria (50, 51) . These factors likely contribute to over-estimation of the reduction in the growth rate due to the double mutation (CHA19CHA20) compared to CHA19 and CHA20 single mutants. To overcome this, explicit solvent simulations were deployed in the current work, which enables more realistic transition rates to be computed and allows better sampling of peptide conformational fluctuations in non-registered as well as registered states. The non-registered conformations sampled will be clustered based on the peptide structure and peptidefibril contacts. These clustered states will then be added to the MSM. In addition, we will introduce a new type of transition between registered states, which involves peptide conformational changes.
These transitions will also be necessary when extending the current framework to longer peptides. We define registered states by orientation of the incoming peptide (antiparallel or parallel), surfaces of the incoming and fibril core (odd or even), shift (the alignment of the incoming peptide relative to the template), free chain length (FCL, the number of dissociated residues of the incoming peptide starting from the N-or C-terminus), and the number of hydrogen bonds ( Fig. 2 A, B). Simulations were performed to sample the transitions between these registered states as well as transitions between registered and non-registered states ( Fig. 2 C and D, SI Table 1 ). The definition of states and simulation system set-up is described in detail in the Methods section. 
H-bond transition rates of wild type and mutated
Molecular origins of slow fibril growth and mutations effects
To derive the overall fibril growth kinetics, 10000 MSM simulations were performed, with 5000 each on the even and odd faces of the fibril core, to calculate τresidence and Pcommittor (eq. 1). Each simulation was initiated from the separation distance b and terminated when the incoming strand reached the antiparallel fully H-bonded in-register state or the escape distance q. Pcommittor was calculated as the probability of MSM trajectories reaching the fully H-bonded in-register state, and τresidence is the average length of all trajectories (Fig, 1B) . To calculate τoff, another set of 10000 MSM simulations was initiated from the antiparallel in-register fully bound state and performed until the strand reached the escape distance q. Pcommittor is nearly doubled compared to our previous study with implicit solvent and without clustering of the non-registered state ( Table 1 ). This suggests the in-register states are more stable for Aβ16-22 in the explicit solvent model. In addition, both τresidence and τoff, are increased by 2~3 orders of magnitude from the previous study due to the increased residence time of each state (Table 1) . To compare with experimental results, the elongation rate as a function of monomer concentration is estimated. The diffusion time (τdiff, eq. 1) is estimated as τdiff = 1/ kcoll Cmonomer, in which Cmonomer is concentration of peptide monomer and kcoll is collision rate constant. The kcoll is defined as kcoll = 4πσDmonomer, in which the in which σ is the reaction cross section (b surface in our simulation, 28 Å) and Dmonomer is the diffusion coefficient (determined from experiments to be 1.7x10 -6 cm 2 /s) (14) . The results plotted in Fig. 6 suggest the critical concentration of peptide monomer (Cc) from the MSM model is ~8 µM, which is close to the experimental result of ~33 µM (40) . The ability of the current multi-scale modeling approach to recapitulate the critical concentration to a factor of ~4 without adjustable parameters is noteworthy, particularly considering the comprehensive description of nonspecific and specific reversible binding and the conformational search process. This also likely reflects improvements in explicit solvent force field quality made in recent years. (52, 53) Experimental studies have suggested that CHA mutation on 19 and 20 positions have non-additive effects on overall aggregation kinetics (the growth rate: wt << CHA19 < CHA1920 < CHA20 under high monomer concentration (> 40 µM). However, this result could not be directly explained by thermodynamic effects of the mutations, which appear to have an additive effect (the ΔΔG with respect to wt for CHA19, CHA20, and CHA1920 are 0.2 kcal.mol -1 , -0.2 kcal.mol -1 and 0.0 kcal.mol -1 , respectively) (40) . To investigate the influence of mutations, MSM simulations of CHA mutants were performed. In the initial high monomer concentration condition, both CHA19 and CHA1920 exhibited significant kinetic enhancement in fibril elongation ( Fig. 6 ), in agreement with experiments. (40) This corresponds to the initial stage (0-2h) characterized by a fast decrease in the monomer concentration. This rapid aggregation reduces the monomer concentration leading to an increase of τdiff, which in turn, leads to a decrease of kgrowth. After the monomer is further depleted the growth rate approaches zero, which suggests that kon is close to koff. This is the plateau region where the monomer peptide concentration approaches the critical concentration of peptide monomer (Cc). (40) Our results also suggest that the wt and CHA mutated peptides have similar τdiff when kgrowth is 0. This is because the time for peptide rearrangement on the fibril surface is much smaller than the diffusion time (τresidence << τdiff) in this stage. The elongation is then governed by the diffusion process and the effect of mutation can be neglected. This is consistent with the similar measured Cc for wt, CHA19 and CHA1920 (33, 32, 44 µM, respectively) .
To investigate the association/dissociation pathways, all MSM trajectories were combined and the relevant free energy of each H-bonding state was plotted ( Fig. 7) . In marked contrast to the funnel shaped free energy landscape of native proteins (41, 43) , the free energy of Aβ16-22 is relatively flat.
The free energy difference between the in-register sub-states and misregistered sub-states are < 5 kcal/mol. Although the in-register states are more thermodynamically stable (Fig. 5 ), to reach these states an incoming Aβ16-22 peptide needs to visit different mis-registered states an average of ~22 times before it forms the fully bound in-registered states. The ratio of mis-registered states in amyloid is much higher than the misfolded trapped states observed in natural proteins. (54, 55) Our trajectories suggest a molecular interpretation for the "Dock and Lock" model for fibril growth. (12) (13) (14) (15) . The slow "lock" stage that follows fast nonspecific binding ("dock") involves a random walk among the non-registered and mis-registered states before the peptide eventually finds the in-register state. The large values of Pcommittor derived from atomistic simulations ( Table   1) show that molecules reaching the docked state are much more likely to proceed to the locked states than to detach. The slow fibril growth rate can be attributed to the time the peptide spends to "antiparallel e|e|0 FCL 6" sub-state) is derived from all MSM trajectories. The two in-registered states "antiparallel e|e|0" and "antiparallel o|o|0" are highlighted in red. The fully bound "antiparallel e|e|0" state is labelled with a red asterisk.
To further investigate the influence of mutations, we examine the origin of the change in elongation rate for the mutated peptides. The increased growth rate of the mutants is due to a decrease of τresidence, which in turn, arises from destabilizing two main trap states, "parallel o|o|0" and "parallel e|o|-2" ( Table 2) . Although the relative free-energy of registered states between the CHA19 and CH1920 double mutation is similar, the double mutation also leads to a decrease in the residence time of in-registered states (Table S2) . which leads to a faster dissociation rate (smaller τoff) and a decrease in the growth rate. The influence of non-productive pathways Table 2 shows the free energies for each registry, as estimated from the fraction of time each state was occupied in the MSM. For each molecule the free energies are measured relative to the lowest occupancy registry. In the wt Aβ16-22 peptides, two mis-registered states "parallel o|o|0" and "parallel e|o|-2" were found to have similar free energy compared with the in-register states ( Table   2 ). We offer two mechanisms to explain the dominance of the anti-parallel in-register states over these low energy states in the assembled fibril. First, electrostatic interactions will naturally disfavor parallel states due to the close proximity of both terminal and sidechain charges. The repulsion in due to the N and C terminal charges will be reduced somewhat for molecules at the fibril ends because fluctuations in the binding states will allow the charges to separate. However, when the next molecule attaches, those termini will get pinned down, resulting in the full electrostatic repulsion. This effect is amplified with each additional parallel molecule that is added.
The electrostatic contribution from the termini becomes less important with increasing protein length, which explains the parallel structures of full-length Aβ, IAPP, and others. In addition, mutations which weaken these repulsions may allow these non-productive pathways to dominate fibril assembly. This assumption is consistent with NMR experiments showing that the E22Q mutation leads to parallel fibrils. (56) Interestingly, this mutation is the same as the Dutch mutant of full-length Aβ peptide which enhances the aggregation propensity. (57) Secondly, while mis-registered states, like parallel e|o|-2, bind with high affinity, they may offer a poor template for subsequent fibril growth. An out-of-register shift will result in overhanging amino acids that will bind poorly to subsequent molecules due to the conformational entropy penalty of immobilizing the flexible residues.(58) However, under conditions conducive to rapid growth (e.g. when the monomer concentration is high), these registry defects may be trapped within the growing fibril by subsequent monomer addition.(59)
Conclusion
Functional proteins have evolved to develop efficient folding pathways where a funnel-shaped free energy landscape reduces the time spent exploring non-productive states. This evolutionary pressure does not exist for non-functional states like pathological aggregates. In these cases, the free energy landscape would more closely resemble a golf course (41) or an inverted funnel (59) .
Without the guidance of a biased landscape, the conformational search will resemble a random search over binding states. This is the situation we find in our simulations. Instead of finding a few dominant pathways or intermediate states, the effects of mutations emerge from the accumulation of small perturbations over the ensemble of partially bound states. This poses new challenges for computational methods, which must sample both productive and non-productive pathways to generate meaningful predictions. We have demonstrated how insights from analytic theory can be utilized to meet this challenge by inspiring sampling techniques that can access new timescales and provide a more complete understanding of fibril growth.
Methods
A total of 719 µs explicit simulation in the CHARMM36m all-atom force field (60, 61) was performed to derive the microscopic kinetic parameters for transition among all H-bonded and nonspecific bound states. Please see SI Supporting Text for detailed simulation and analysis procedures.
